Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier

References

• Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36(3):437–12. doi:10.1007/s10545-013-9608-0. PMID: 23609350.
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7(1):41–53. doi:10.1038/nrn1824. PMID: 16371949.
   PubMed Web of Science ®Google Scholar
• Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412. PMID: 25561720.
   PubMed Web of Science ®Google Scholar
• Villaseñor R, Lampe J, Schwaninger M, Collin L. Intracellular transport and regulation of transcytosis across the blood-brain barrier. Cell Mol Life Sci. 2019;76(6):1081–92. doi:10.1007/s00018-018-2982-x. PMID: 30523362.
   PubMed Web of Science ®Google Scholar
• Preston JE, Joan Abbott N, Begley DJ. Transcytosis of macromolecules at the blood-brain barrier. Adv Pharmacol. 2014;71:147–63. doi:10.1016/bs.apha.2014.06.001. PMID: 25307216.
   PubMedGoogle Scholar
• Lajoie JM, Shusta EV. Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. Annu Rev Pharmacol Toxicol. 2015;55:613–31. doi:10.1146/annurev-pharmtox-010814-124852. PMID: 25340933.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem. 2008;19(7):1327–38. doi:10.1021/bc800148t. PMID: 18547095.
   PubMed Web of Science ®Google Scholar
• Boado RJ. IgG fusion proteins for brain delivery of biologics via blood–brain barrier receptor-mediated transport. Pharmaceutics. 2022;14(7):1476. doi:10.3390/pharmaceutics14071476. PMID: 35890374.
   PubMed Web of Science ®Google Scholar
• Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk RM. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci USA. 1991;88(11):4771–75. doi:10.1073/pnas.88.11.4771. PMID: 2052557.
   PubMed Web of Science ®Google Scholar
• Shin SU, Friden P, Moran M, Olson T, Kang YS, Pardridge WM, Morrison SL. Transferrin-antibody fusion proteins are effective in brain targeting. Proc Natl Acad Sci USA. 1995;92(7):2820–24. doi:10.1073/pnas.92.7.2820. PMID: 7708731.
   PubMed Web of Science ®Google Scholar
• Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, Atwal J, Elliott JM, Prabhu S, Watts RJ, et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med. 2011;3(84):84ra44. doi:10.1126/scitranslmed.3002230. PMID: 21613623.
   PubMed Web of Science ®Google Scholar
• Niewoehner J, Bohrmann B, Collin L, Urich E, Sade H, Maier P, Rueger P, Stracke JO, Lau W, Tissot AC, et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron. 2014;81(1):49–60. doi:10.1016/j.neuron.2013.10.061. PMID: 24411731.
   PubMed Web of Science ®Google Scholar
• Thom G, Burrell M, Haqqani AS, Yogi A, Lessard E, Brunette E, Delaney C, Baumann E, Callaghan D, Rodrigo N, et al. Enhanced delivery of galanin conjugates to the brain through bioengineering of the anti-transferrin receptor antibody OX26. Mol Pharm. 2018;15(4):1420–31. doi:10.1021/acs.molpharmaceut.7b00937. PMID: 29485883.
   PubMed Web of Science ®Google Scholar
• Kariolis MS, Wells RC, Getz JA, Kwan W, Mahon CS, Tong R, Kim DJ, Srivastava A, Bedard C, Henne KR, et al. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci Transl Med. 2020;12(545): doi: 10.1126/scitranslmed.aay1359. PMID: 32461332.
   Web of Science ®Google Scholar
• Sehlin D, Stocki P, Gustavsson T, Hultqvist G, Walsh FS, Rutkowski JL, Syvänen S. Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle. Faseb J. 2020;34(10):13272–83. doi:10.1096/fj.202000610RR. PMID: 32779267.
   PubMed Web of Science ®Google Scholar
• Okuyama T, Eto Y, Sakai N, Minami K, Yamamoto T, Sonoda H, Yamaoka M, Tachibana K, Hirato T, Sato Y. Iduronate-2-sulfatase with anti-human transferrin receptor antibody for neuropathic mucopolysaccharidosis II: a phase 1/2 trial. Mol Ther. 2019;27(2):456–64. doi:10.1016/j.ymthe.2018.12.005. PMID: 30595526.
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Kang YS, Buciak JL, Yang J. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res. 1995;12(6):807–16. doi:10.1023/a:1016244500596. PMID: 7667183.
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Boado RJ, Giugliani R, Schmidt M. Plasma pharmacokinetics of valanafusp alpha, a human insulin receptor antibody-iduronidase fusion protein, in patients with mucopolysaccharidosis type i. BioDrugs. 2018;32(2):169–76. doi:10.1007/s40259-018-0264-7. PMID: 29442294.
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Shinohara T, Adachi Y, Asami T, Ohtaki T. A novel LRP1-binding peptide L57 that crosses the blood brain barrier. Biochem Biophys Rep. 2017;12:135–39. doi:10.1016/j.bbrep.2017.07.003. PMID: 29090274.
   PubMedGoogle Scholar
• Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem. 2008;106(4):1534–44. doi:10.1111/j.1471-4159.2008.05492.x. PMID: 18489712.
   PubMed Web of Science ®Google Scholar
• Zuchero YJ, Chen X, Bien-Ly N, Bumbaca D, Tong RK, Gao X, Zhang S, Hoyte K, Luk W, Huntley MA, et al. Discovery of novel blood-brain barrier targets to enhance brain uptake of therapeutic antibodies. Neuron. 2016;89(1):70–82. doi:10.1016/j.neuron.2015.11.024. PMID: 26687840.
   PubMed Web of Science ®Google Scholar
• Christensen SC, Krogh BO, Jensen A, Andersen CBF, Christensen S, Nielsen MS. Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain. Sci Rep. 2020;10(1):14582. doi:10.1038/s41598-020-71286-2. PMID: 32884039.
   PubMed Web of Science ®Google Scholar
• Story CM, Mikulska JE, Simister NE. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med. 1994;180(6):2377–81. doi:10.1084/jem.180.6.2377. PMID: 7964511.
   PubMed Web of Science ®Google Scholar
• Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol. 1996;157(8):3317–22. doi:10.4049/jimmunol.157.8.3317. PMID: 8871627.
   PubMed Web of Science ®Google Scholar
• Spiekermann GM, Finn PW, Ward ES, Dumont J, Dickinson BL, Blumberg RS, Lencer WI. Receptor-mediated immunoglobulin g transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med. 2002;196(3):303–10. doi:10.1084/jem.20020400. PMID: 12163559.
   PubMed Web of Science ®Google Scholar
• McCarthy KM, Yoong Y, Simister NE. Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: a system to study protein transport across epithelia. J Cell Sci. 2000;113(Pt 7):1277–85. doi:10.1242/jcs.113.7.1277. PMID: 10704378.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Suzuki Y, Tsuge T, Okumura K, Ra C, Tomino Y. FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells. Am J Physiol Renal Physiol. 2002;282(2):F358–365. doi:10.1152/ajprenal.0164.2001. PMID: 11788451.
   PubMed Web of Science ®Google Scholar
• Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature. 1989;337(6203):184–87. doi:10.1038/337184a0. PMID: 2911353.
   PubMed Web of Science ®Google Scholar
• Rodewald R. Ph-dependent binding of immunoglobulins to intestinal cells of the neonatal rat. J Cell Biol. 1976;71(2):666–69. doi:10.1083/jcb.71.2.666. PMID: 11223.
   PubMed Web of Science ®Google Scholar
• Medesan C, Radu C, Kim JK, Ghetie V, Ward ES. Localization of the site of the IgG molecule that regulates maternofetal transmission in mice. Eur J Immunol. 1996;26(10):2533–36. doi:10.1002/eji.1830261038. PMID: 8898970.
   PubMed Web of Science ®Google Scholar
• Garg A, Balthasar JP. Investigation of the influence of FcRn on the distribution of IgG to the brain. Aaps J. 2009;11(3):553–57. doi:10.1208/s12248-009-9129-9. PMID: 19636712.
   PubMed Web of Science ®Google Scholar
• Abuqayyas L, Balthasar JP. Investigation of the role of FcγR and FcRn in mAb distribution to the brain. Mol Pharm. 2013;10(5):1505–13. doi:10.1021/mp300214k. PMID: 22838637.
   PubMedGoogle Scholar
• Ruano-Salguero JS, Lee KH. Antibody transcytosis across brain endothelial-like cells occurs nonspecifically and independent of FcRn. Sci Rep. 2020;10(1):3685. doi:10.1038/s41598-020-60438-z. PMID: 32111886.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Pardridge WM. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol. 2001;114(1–2):168–72. doi:10.1016/s0165-5728(01)00242-9. PMID: 11240028.
   PubMed Web of Science ®Google Scholar
• Cooper PR, Ciambrone GJ, Kliwinski CM, Maze E, Johnson L, Li Q, Feng Y, Hornby PJ. Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn. Brain Res. 2013;1534:13–21. doi:10.1016/j.brainres.2013.08.035. PMID: 23978455.
   PubMed Web of Science ®Google Scholar
• Dall’acqua WF, Woods RM, Ward ES, Palaszynski SR, Patel NK, Brewah YA, Wu H, Kiener PA, Langermann S. Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences. J Immunol. 2002;169(9):5171–80. doi:10.4049/jimmunol.169.9.5171. PMID: 12391234.
   PubMed Web of Science ®Google Scholar
• Sommer I, Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol. 1981;83(2):311–27. doi:10.1016/0012-1606(81)90477-2. PMID: 6786942.
   PubMed Web of Science ®Google Scholar
• Maxwell DS, Pease DC. The electron microscopy of the choroid plexus. J Biophys Biochem Cytol. 1956;2(4):467–74. doi:10.1083/jcb.2.4.467. PMID: 13357511.
   PubMedGoogle Scholar
• Hurley JV, Anderson RM, Sexton PT. The fate of plasma protein which escapes from blood vessels of the choroid plexus of the rat–an electron microscope study. J Pathol. 1981;134(1):57–70. doi:10.1002/path.1711340107. PMID: 7288528.
   PubMed Web of Science ®Google Scholar
• Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, et al. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem. 2001;276(9):6591–604. doi:10.1074/jbc.M009483200. PMID: 11096108.
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Christianson GJ, Sproule TJ, Brown AC, Akilesh S, Jung N, Petkova S, Avanessian L, Choi EY, Shaffer DJ, et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol. 2003;170(7):3528–33. doi:10.4049/jimmunol.170.7.3528. PMID: 12646614.
   PubMed Web of Science ®Google Scholar
• Jamieson JJ, Searson PC, Gerecht S. Engineering the human blood-brain barrier in vitro. J Biol Eng. 2017;11:37. doi:10.1186/s13036-017-0076-1. PMID: 29213304.
   PubMed Web of Science ®Google Scholar
• Carrodus NL, Teng KS, Munro KM, Kennedy MJ, Gunnersen JM. Differential labeling of cell-surface and internalized proteins after antibody feeding of live cultured neurons. J Vis Exp. 2014;84(84):e51139. doi:10.3791/51139-v. PMID: 24561550.
   Google Scholar
• Chung S, Nguyen V, Lin YL, Lafrance-Vanasse J, Scales SJ, Lin K, Deng R, Williams K, Sperinde G, Li JJ, et al. An in vitro FcRn-dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans. MAbs. 2019;11(5):942–55. doi:10.1080/19420862.2019.1605270. PMID: 30982394.
   PubMed Web of Science ®Google Scholar
• Grevys A, Nilsen J, Sand KMK, Daba MB, Øynebråten I, Bern M, McAdam MB, Foss S, Schlothauer T, Michaelsen TE, et al. A human endothelial cell-based recycling assay for screening of FcRn targeted molecules. Nat Commun. 2018;9(1):621. doi:10.1038/s41467-018-03061-x. PMID: 29434196.
   PubMed Web of Science ®Google Scholar
• Weflen AW, Baier N, Tang QJ, Van den Hof M, Blumberg RS, Lencer WI, Massol RH, Gruenberg JE. Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules. Mol Biol Cell. 2013;24(15):2398–405. doi:10.1091/mbc.E13-04-0174. PMID: 23741050.
   PubMed Web of Science ®Google Scholar
• Tsao D, Thomsen HK, Chou J, Stratton J, Hagen M, Loo C, Garcia C, Sloane DL, Rosenthal A, Lin JC. TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology. 2008;149(3):1038–48. doi:10.1210/en.2007-1166. PMID: 18063676.
   PubMed Web of Science ®Google Scholar
• Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, Nestler EJ. Extracellular signal-regulated protein kinases (erks) and erk kinase (mek) in brain: regional distribution and regulation by chronic morphine. J Neurosci. 1995;15(2):1285–97. doi:10.1523/JNEUROSCI.15-02-01285.1995. PMID: 7532701.
   PubMed Web of Science ®Google Scholar
• Kim GS, Cho S, Nelson JW, Zipfel GJ, Han BH, Gressens P. Trkb agonist antibody pretreatment enhances neuronal survival and long-term sensory motor function following hypoxic ischemic injury in neonatal rats. PLoS One. 2014;9(2):e88962. doi:10.1371/journal.pone.0088962. PMID: 24551199.
   PubMed Web of Science ®Google Scholar
• Latvala S, Jacobsen B, Otteneder MB, Herrmann A, Kronenberg S. Distribution of FcRn across species and tissues. J Histochem Cytochem. 2017;65(6):321–33. doi:10.1369/0022155417705095. PMID: 28402755.
   PubMed Web of Science ®Google Scholar
• Datta-Mannan A, Witcher DR, Tang Y, Watkins J, Wroblewski VJ. Impact of modulating the interaction of IgG with the neonatal Fc receptor. J Biol Chem. 2007;282(3):1709–17. doi:10.1074/jbc.M607161200. PMID: 17135257.
   PubMed Web of Science ®Google Scholar
• Zalevsky J, Chamberlain AK, Horton HM, Karki S, Leung IWL, Sproule TJ, Lazar GA, Roopenian DC, Desjarlais JR. Enhanced antibody half-life improves in vivo activity. Nat Biotechnol. 2010;28(2):157–59. doi:10.1038/nbt.1601. PMID: 20081867.
   PubMed Web of Science ®Google Scholar
• Ghetie V, Popov S, Borvak J, Radu C, Matesoi D, Medesan C, Ober RJ, Ward ES. Increasing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol. 1997;15(7):637–40. doi:10.1038/nbt0797-637. PMID: 9219265.
   PubMed Web of Science ®Google Scholar
• Vaccaro C, Zhou J, Ober RJ, Ward ES. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol. 2005;23(10):1283–88. doi:10.1038/nbt1143. PMID: 16186811.
   PubMed Web of Science ®Google Scholar
• Lin C-Y, Riggers JFC, Grishanin RN, Stratton JR, Zhai W. Agonist anti-trkb monoclonal antibodies. International patent application WO2010086828A2; 2010 Jan 29.
   Google Scholar
• Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest. Maryland (USA): National Institutes of Health; 1991.
   Google Scholar
• Edelman GM, Cunningham BA, Gall WE, Gottlieb PD, Rutishauser U, Waxdal MJ. The covalent structure of an entire gammaG immunoglobulin molecule. Proc Natl Acad Sci USA. 1969;63(1):78–85. doi:10.1073/pnas.63.1.78. PMID: 5257969.
   PubMed Web of Science ®Google Scholar
• Dall’acqua WF, Kiener PA, Wu H. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem. 2006;281(33):23514–24. doi:10.1074/jbc.M604292200. PMID: 16793771.
   PubMed Web of Science ®Google Scholar
• Titani K, Shinoda T, Putnam FW. The amino acid sequence of a kappa type Bence-Jones protein. 3. The complete sequence and the location of the disulfide bridges. J Biol Chem. 1969;244(13):3550–60. doi:10.1016/S0021-9258(18)83405-6. PMID: 4893682.
   PubMed Web of Science ®Google Scholar
• Breiman L. Random forests. Mach Learn. 2001;45(1):5–32. doi:10.1023/A:1010933404324.
   Web of Science ®Google Scholar